1. Home
  2. IMC vs ACHV Comparison

IMC vs ACHV Comparison

Compare IMC & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IMC Rare Earths Ltd Ordinary Shares

IMC

IMC Rare Earths Ltd Ordinary Shares

N/A

Current Price

$10.72

Market Cap

728.3M

ML Signal

N/A

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

N/A

Current Price

$6.69

Market Cap

726.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IMC
ACHV
Founded
2025
N/A
Country
Brazil
United States
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
728.3M
726.5M
IPO Year
2026
2018

Fundamental Metrics

Financial Performance
Metric
IMC
ACHV
Price
$10.72
$6.69
Analyst Decision
Strong Buy
Analyst Count
0
12
Target Price
N/A
★ $14.15
AVG Volume (30 Days)
106.8K
★ 1.3M
Earning Date
11-10-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.80
$2.62
52 Week High
$12.00
$8.64

Technical Indicators

Market Signals
Indicator
IMC
ACHV
Relative Strength Index (RSI) 63.90 44.06
Support Level $6.23 $5.96
Resistance Level $11.84 $7.30
Average True Range (ATR) 1.16 0.38
MACD 0.48 0.04
Stochastic Oscillator 73.33 43.93

Price Performance

Historical Comparison
IMC
ACHV

About IMC IMC Rare Earths Ltd Ordinary Shares

IMC Rare Earths Ltd is a mineral exploration and development company engaged in the exploration, evaluation and development of minerals and metals in Brazil. Its main REE project is the Itarantim Project located in the States of Bahia and Minas Gerais, Brazil.

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

Share on Social Networks: